UCI receives 5-year, $5 million CIRM award for training of diverse researchers

The University of California, Irvine has received a five-year, $5 million award from the California Institute for Regenerative Medicine to support a comprehensive doctoral, postdoctoral and clinical researcher training program to prepare the current and next generation of leaders in stem cell biology, gene therapy and regenerative medicine.

$1.3 million in NIH grants to enable research into antibody-mediated drug delivery technology

Two National Institute of Health (NIH) grants totaling over $1.3 million will enable research into antibody-mediated drug delivery technology for the treatment of cancer and autoimmune disorders. L. Nathan Tumey, assistant professor of pharmaceutical sciences, is the Principal Investigator on both grants — $1.2 million from the National Institute of General Medical Sciences and $150,000 from the National Institute of Allergy and Infectious Diseases.

Chula Virtual International Graduate Open House Academic Year 2021-2022

Join us at our Virtual Graduate Open House (International) to find out about the diverse range of international programs available and the benefits of studying at Chula. Organized by the Office of International Affairs and Global Network (OIA), during August 31 – September 3, 2021, at 1.00 – 4.00 PM (GMT +7) via Zoom webinars and Facebook Live, the event is an ideal way to explore the graduate programs, connect with faculty and staff, get answers to your questions about graduate school, and get details on deadlines, funding, career paths, specific requirements, and much more.

Diverse DNA signatures linked to heart disease

Risk for heart disease does not look the same on the genetic level for different population groups, report an international team of researchers this month in the journal JAMA Cardiology. The study, led by Texas Biomedical Research Institute (Texas Biomed) and Columbia University Mailman School of Public Health, begins to outline gene activity patterns that could serve as early warning indicators for cardiovascular disease.

What you need to know about the delta variant

For more than 40 years, UCI infectious disease researcher Michael Buchmeier has studied coronaviruses, and he’s one of the leading experts on SARS-CoV-2, the version of the virus causing the COVID-19 pandemic. As a more lethal mutation of the virus, called the delta variant, sparks another wave of cases, he offers his expertise about this threat.

Soft Launching of the School of Global Health, Faculty of Medicine, Chulalongkorn University

The School of Global Health was established with the aim to serve as a platform to combine the management of the international programs in order to upgrade the graduate program and lifelong education while at the same time producing a new breed of graduates strengthen those with capabilities and potentials to meet the expectations of society for all professions related to the health and well-being system in Thailand as well as in foreign countries.

Equity and Vaccine Allocation: Beyond Ethics in Prioritization to Equitable Production, Distribution, and Consumption

In a new paper in Ethics & International Affairs, Binghamton University Professor of Philosophy Nicole Hassoun first considers existing proposals for equitable vaccine allocation focusing on the COVID-19 Vaccines Global Access (COVAX) facility. She then argues that to better promote…

Population-specific diversity within fungi species could enable improved drug discovery

Scientists at Oak Ridge National Laboratory and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in medicine, industry and agriculture.

Using Computation to Improve Words: Model Offers Novel Tool for Improving Serious Illness Conversations

Conversations between seriously ill people, their families and palliative care specialists lead to better quality-of-life. Understanding what happens during these conversations – and how they vary by cultural, clinical, and situational contexts – is essential to guide healthcare communication improvement efforts. To gain true understanding, new methods to study conversations in large, inclusive, and multi-site epidemiological studies are required. A new computer model offers an automated and valid tool for such large-scale scientific analyses.

UCI professor wins Spain’s prestigious Princess of Asturias award for scientific research

Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.

Bio-inspired hydrogel protects the heart from post-op adhesions

A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers. The team of engineers, scientists and physicians also conducted a pilot study on porcine hearts, with promising results.

They describe their work in the June 18, 2021 issue of Nature Communications.

Renowned Alzheimer’s Clinical Trials Researcher Available to Comment on June 7 FDA Approval of Aducanumab

The Food and Drug Administration on June 7 approved Aducanumab, which will carry the brand name Aduhelm, as the first new treatment for Alzheimer’s disease in nearly 20 years. Dr. Jeffrey L. Cummings, UNLV research professor and leading expert on Alzheimer’s clinical trials, calls…

Covid-19 vaccines also protect unvaccinated family members

Researchers at the Helsinki Graduate School of Economics have found that the Pfizer-BioNTech and Moderna Covid-19 vaccines protect both vaccinated individuals and their unvaccinated adult household members against SARS-CoV-2 infections. The study, not yet peer-reviewed, used Finnish administrative datasets to examine the link between mRNA-based Covid-19 vaccines and infection risk among vaccinated individuals as well as their unvaccinated family members.

Efforts to treat COVID-19 patients chronicled in UC Health medications data

Irvine, Calif., May 21, 2021 – A record of medicine utilization patterns assembled by an interdisciplinary team of researchers at the University of California, Irvine and the UC San Diego School of Medicine reveals the thought, care and scientific rigor clinicians at UC Health medical centers applied in their treatment of patients with COVID-19 in 2020.

UCI biomedical engineers spotlight disparities in knee and jaw joint treatments

Irvine, Calif., May 5, 2021 – If you haven’t had knee surgery, you may have a friend or relative who has. But do you know anyone who has had an operation on their jaw? Although the temporomandibular joint is crucial to speaking, chewing and even breathing, treatments for TMJ disorders are far less common than those for the knee.

Rutgers Champion of Student Health and Wellness is Retiring

When Melodee Lasky joined Rutgers University 19 years ago, behavioral and mental health services were scattered across the individual colleges with little coordination. Psychiatry and the Alcohol and Other Drug Assistance Program were part of student health, but counseling services were separated and college-affiliated. Lasky, a physician who recognized the connection between physical and emotional wellness, recommended that mental and behavioral health be integrated within the framework of student health. That led to the creation of CAPS – Counseling, Alcohol and Other Drug Assistance Program & Psychiatric Services – a program that helps about 4,500 students each year.

University of Chicago scientists design “Nanotraps” to catch and clear coronavirus from tissue

Researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have designed a completely novel potential treatment for COVID-19: nanoparticles that capture SARS-CoV-2 viruses within the body and then use the body’s own immune system to destroy it.

Rutgers Expert Available to Discuss Spring Allergy Season in N.J.

New Brunswick, N.J. (April 20, 2021) – Rutgers University–New Brunswick allergy specialist Leonard Bielory is available for interviews on the spring allergy season in New Jersey. “One can expect a brisk allergy season this year since we had a lot…

UCI to lead transfer of UC COVID-19 patient information to federal database

Irvine, Calif., March 24, 2021 – Vaccines are here, but as COVID-19 cases continue and variants spread, researchers need easy access to a wide variety of data to better understand the disease. Led by the University of California, Irvine, UC hospitals have received a $500,000 grant from the National Institutes of Health to make this possible.

Do You Know the Way to Berkelium, Californium?

Scientists at Berkeley Lab have demonstrated how to image samples of heavy elements as small as a single nanogram. The new approach will help scientists advance new technologies for medical imaging and cancer therapies.

Speakers Announced for Virtual Experimental Biology 2021 Meeting

Renowned scientists—including Nobel laureates, research pioneers and celebrated educators—will speak at the virtual Experimental Biology (EB) 2021 meeting, to be held April 27–30. Bringing together thousands of life scientists in one interdisciplinary community, EB showcases the latest advances in anatomy, biochemistry, molecular biology, investigative pathology, pharmacology and physiology.

Psychedelic Science Holds Promise for Mainstream Medicine

A team of UNLV neuroscientists are uncovering how psychedelics affect brain activity. Their work, published recently in Nature: Scientific Reports, shows a strong connection in rodent models between brain activity and behaviors resulting from psychedelic treatment, a step forward in the quest to better understand their potential therapeutic effects.

Leveraging Modeling and Simulation in Medicine at VisualizeMED

ASME’s VisualizeMED: Modeling and Simulation in Medicine will take place on April 14-15, 2021. This two-day virtual event is enabling the transformation of modeling and simulation in medicine by bringing together industry experts of technology and masters of technique who are effectively implementing it with the goal to increase the application and adoption on a global scale.

Rutgers University’s Resilient, Innovative Year Confronting COVID-19

The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.

Researchers watch anti-cancer drug release from DNA nanostructures in real time

A team of researchers from Finland and Germany have found a way to study the endonuclease-driven digestion of drug-loaded DNA nanostructures in real time. As the team investigated the binding of anti-cancer drug doxorubicin (Dox) to the DNA structures in great detail, they discovered that the majority of previous studies have vastly overestimated the Dox loading capacity of DNA origami.

Press Registration Now Open for Virtual Experimental Biology 2021 Meeting

Complimentary press passes are now available for the virtual Experimental Biology (EB) 2021 meeting, to be held April 27–30. EB is the annual meeting of five scientific societies bringing together thousands of scientists and 25 guest societies in one interdisciplinary community.

University of Northern Colorado Associate Professor Nick Pullen Provides Expertise on COVID-19 Vaccinations

Nick Pullen, Ph.D., an associate professor of Biological Sciences at the University of Northern Colorado (UNC), provides expertise regarding the topic of COVID-19 vaccinations and immunity.  Pullen’s research centers around the body’s immune response, specifically chronic inflammation, asthma and allergies.…